According to DICE Therapeutics's latest financial reports the company's current EPS (TTM) is -$2.34. In 2022 the company made an earnings per share (EPS) of -$2.14 an increase over its 2021 EPS that were of -$3.30.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$2.34 | 9.35% |
2022 | -$2.14 | -35.19% |
2021 | -$3.30 |